Blog
Discover the stories and breakthroughs that continue to change cancer outcomes across British Columbia.
Ovarian cancer researchers request practice changes to protect against ovarian cancer
VANCOUVER, BC - Gynecologic oncologists with the Ovarian Cancer Research Program at Vancouver General Hospital (VGH) and the BC Cancer Agency have begun …
Unveiling our new Partners in Discovery blog
I’m excited to share our new Partners in Discovery blog with you. Partners in Discovery represents our partnerships with the people who are helping us achieve our vision …
1,110 participants begin day two of $2.4 million, 60-km Weekend Walk BC Cancer Foundation’s 7th annual fundraiser a signature success
August 15, 2010, Vancouver, BC - The BC Cancer Foundation announced yesterday that 1,100 participants raised over $2.4 million in its seventh annual Shoppers …
One step closer to personalized medicine
There’s exciting news coming out of the Genome Sciences Centre (GSC)today that brings us one step closer …
Personalized genome sequencing in cancer treatment—a major breakthrough in care
August 9, 2010, Vancouver, BC – Researchers at the BC Cancer Agency Genome Sciences Centre have provided the first published example of genome-scale RNA …
Scientists discover cancer-causing gene — helping to distinguish lung cancer subtypes
Researchers identified a cancer-causing gene, BRF2, specific to squamous lung cell carcinoma, which could be a marker for this type of lung cancer and …
Running in our undies
The weather was perfect Saturday night for our fifth annual Underwear Affair where 925 participants raised $552,500 for cancers below the waist, such as …
Model citizens raise funds for cancer
Last night was a blast! Thanks to the wonderful people at CHMB AM1320, the BC Cancer Foundation was the charity …
Strength in numbers
What a weekend! The second Ride to Conquer Cancer was an overwhelming success, with 2,252 riders raising $9.2 million for cancer research right …
BC scientists develop new drug candidate for prostate cancer
June 15, 2010, Vancouver, B.C. – Scientists in B.C. have developed a unique experimental drug, EPI-001, that shrinks prostate cancer tumours in the lab. …